Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 1/20 | 0.43 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | ELANE | P08246 | 5/20 | 0.34 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.33 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.33 |
| ▸ | BTN3A1 | O00481 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6879319 | 0.91 | ALDH1A1 (0.39) | PRKCASERPINE1POLBGAANPSR1 | |
| SCHEMBL24877573 | 0.89 | PRKCA (0.37) | PRKCASERPINE1POLBGAANPSR1 | |
| SCHEMBL9348634 | 0.87 | PRKCA (0.44) | PRKCASERPINE1POLBGAANPSR1 | |
| SCHEMBL13686650 | 0.87 | PRKCA (0.39) | PRKCASERPINE1POLBGAANPSR1 | |
| SCHEMBL12571028 | 0.85 | PRKCA (0.38) | PRKCASERPINE1POLBGAANPSR1 | |
| SCHEMBL24883882 | 0.85 | PRKCA (0.38) | PRKCASERPINE1POLBGAANPSR1 | |
| SCHEMBL1710469 | 0.85 | PRKCA (0.38) | PRKCASERPINE1POLBGAANPSR1 | |
| SCHEMBL15891838 | 0.83 | PRKCA (0.43) | PRKCAPOLBGAANPSR1ELANE | |
| SCHEMBL12561094 | 0.83 | PRKCA (0.43) | PRKCAPOLBGAANPSR1ELANE | |
| SCHEMBL733594 | 0.83 | PRKCA (0.43) | PRKCAPOLBGAANPSR1ELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070190003-A1 | Cosmetic composition comprising a particular ester, and uses thereof | L'OREAL S.A. (FR) | 2007-08-16 | — | — | US | claimed |
| CN-115023271-B | Hair improvement method | 日本精化株式会社 | 2024-01-30 | — | — | CN | disclosed |
| US-20070190003-A1 | Cosmetic composition comprising a particular ester, and uses thereof | L'OREAL S.A. (FR) | 2007-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070190003-A1 | Cosmetic composition comprising a particular ester, and uses thereof | CUTA, MGLL, DAGLA | PRKCA 1529/4885SERPINE1 3048/4885POLB 1103/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.